Arcline Sells Medical Manufacturing Technologies to Perimeter in $685M High-Stakes Deal

0
42

Leadership Backs the Move

Perimeter CEO Haitham Khouri praised MMT as an “excellent fit,” emphasizing its expanding recurring aftermarket demand and deep bench of proprietary engineered components. The company plans to finance the transaction with $500 million in new debt and $185 million in existing cash.

Arcline’s Rapid Scaling of MMT

Since purchasing MMT in 2020, Arcline said it has “executed a disciplined strategy” to build a scaled leader in mission-critical manufacturing technologies, completing 13 targeted acquisitions and significantly expanding revenue. For Arcline, the sale marks the culmination of a focused industrial-tech growth play.

Perimeter, for its part, intends to maintain MMT’s upward trajectory through both organic growth and further M&A opportunities, Khouri confirmed.

Signup for the USA Herald exclusive Newsletter

Legal Teams and Missing Details

Kirkland’s team for Arcline includes partners Rodin M. Hai-Jew, Michael White, and William Dong. Information on the remaining deal teams was not available Thursday.